| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| Incidence, risk factors and outcome of young patients with myocardial infarction J Jortveit, AH Pripp, J Langørgen, S Halvorsen Heart 106 (18), 1420-1426, 2020 | 91 | 2020 |
| 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators … F Schiele, S Aktaa, X Rossello, I Ahrens, MJ Claeys, JP Collet, KAA Fox, ... European Heart Journal Acute Cardiovascular Care 10 (2), 224-233, 2021 | 71 | 2021 |
| Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction S Halvorsen, J Jortveit, P Hasvold, M Thuresson, E Øie BMC Cardiovascular Disorders 16, 1-11, 2016 | 67 | 2016 |
| Trends in mortality of congenital heart defects J Jortveit, N Øyen, E Leirgul, T Fomina, GS Tell, SE Vollset, L Eskedal, ... Congenital heart disease 11 (2), 160-168, 2016 | 60 | 2016 |
| Myocardial infarction in Norway in 2013 J Jortveit, RES Govatsmark, TA Digre, C Risøe, T Hole, J Mannsverk, ... Tidsskrift for Den norske legeforening, 2014 | 60* | 2014 |
| Sudden unexpected death in children with congenital heart defects J Jortveit, L Eskedal, A Hirth, T Fomina, G Døhlen, P Hagemo, GS Tell, ... European heart journal 37 (7), 621-626, 2016 | 53 | 2016 |
| Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease J Jortveit, S Halvorsen, A Kaldal, AH Pripp, RES Govatsmark, ... BMC Cardiovascular Disorders 19, 1-9, 2019 | 48 | 2019 |
| Mortality and complications in 3495 children with isolated ventricular septal defects J Jortveit, E Leirgul, L Eskedal, G Greve, T Fomina, G Døhlen, GS Tell, ... Archives of disease in childhood 101 (9), 808-813, 2016 | 48 | 2016 |
| Gender differences in the assessment and treatment of myocardial infarction J Jortveit, RES Govatsmark, J Langørgen, T Hole, J Mannsverk, S Olsen, ... Tidsskrift for Den norske legeforening, 2016 | 40* | 2016 |
| Endocarditis in children and adolescents with congenital heart defects: a Norwegian nationwide register-based cohort study J Jortveit, J Klcovansky, L Eskedal, S Birkeland, G Døhlen, H Holmstrøm Archives of Disease in Childhood 103 (7), 670-674, 2018 | 38 | 2018 |
| BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a … J Munkhaugen, V Ruddox, S Halvorsen, T Dammen, MW Fagerland, ... American heart journal 208, 37-46, 2019 | 34 | 2019 |
| Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries M Blöndal, T Ainla, J Eha, P Lõiveke, T Marandi, A Saar, G Veldre, ... European Heart Journal-Quality of Care and Clinical Outcomes 8 (3), 307-314, 2022 | 25 | 2022 |
| Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction J Jortveit, AH Pripp, J Langørgen, S Halvorsen European Journal of Preventive Cardiology 26 (13), 1373-1382, 2019 | 23 | 2019 |
| Severe congenital heart defects: incidence, causes and time trends of preoperative mortality in Norway G Wik, J Jortveit, V Sitras, G Døhlen, AE Rønnestad, H Holmstrøm Archives of disease in childhood 105 (8), 738-743, 2020 | 22 | 2020 |
| Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 21 | 2021 |
| User Evaluation of a Smartphone Application for Anticoagulation Therapy. B Smaradottir, SG Martinez, EM Borycki, G Loudon, A Kushniruk, J Jortveit, ... MIE, 466-470, 2018 | 18 | 2018 |
| Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway J Jortveit, AH Pripp, S Halvorsen European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 442-451, 2022 | 16 | 2022 |
| Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction … T Hellgren, M Blöndal, J Jortveit, T Ferenci, J Faxén, C Lewinter, J Eha, ... European Heart Journal Open 2 (4), oeac042, 2022 | 14 | 2022 |
| Prevalence of infective endocarditis in children J Jortveit, L Eskedal, J Klcovansky, G Døhlen, H Holmstrøm Tidsskrift for Den norske legeforening, 2019 | 12 | 2019 |
Sigrun HalvorsenUniversity of OsloVerified email at medisin.uio.no
